A non-invasive measurement and digital monitoring infrastructure for early detection of health trends

Program Objective and Strategic Role

The National Biosensor and Digital Health Monitoring Program aims to establish a nationwide, non-invasive health monitoring infrastructure that uses biosensor-based measurements and digital data processing to enable the continuous observation of health trends, physiological load, and early deviations.

The program is neither diagnostic nor therapeutic. Its role is to:

  • – make unfavorable health trajectories detectable at an early stage,
  • – support prevention and lifestyle-based interventions,
  • – provide a data-driven foundation for institutional and national-level decision-making.

Core Program Logic

The system treats health as a continuously evolving state, placing emphasis on longitudinal trends rather than single-point measurements.

Three integrated levels:

  1. Individual Level – Personal State Monitoring
  • – home-based and wearable biosensor devices
  • – regular, non-invasive measurements
  • – feedback relative to individual baseline states
  1. Institutional Level – Aggregated Observation
  • – analysis of anonymized, aggregated datasets
  • – identification of regional and demographic health trends
  • – support for targeted prevention initiatives
  1. National Level – Strategic Planning
  • – data-informed health policy development
  • – long-term reduction of healthcare system load
  • – stabilization of national digital health infrastructure

Technological and Operational Components

Biosensor Measurement Layer:

  • – proxy measurements related to stress, inflammation, and metabolic load
  • – validated, non-invasive sensor technologies
  • – collection of longitudinal time-series data

Digital Data Processing:

  • – noise filtering and normalization
  • – trend and pattern analysis
  • – generation of comparable population-level indicators

Data Security and Ethics:

  • – voluntary participation based on informed consent
  • – full anonymization and aggregation
  • – transparent and accountable data governance frameworks

Program Phases (2–6 Years)

Phase 1 – Pilot and Technology Validation (Years 1–2)

  • – limited regional or institutional pilot deployment
  • – testing of measurement and data-processing models
  • – collection of public and institutional feedback

Phase 2 – Regional Expansion (Years 3–4)

  • – inclusion of multiple regions
  • – creation of comparable health-trend databases
  • – support for region-specific prevention programs

Phase 3 – Nationwide Operation (Years 5–6)

  • – stable, nationwide health monitoring system
  • – regular national health trend reports
  • – continuous strategic decision support

Institutional Stakeholders

  • – public health and healthcare institutions
  • – digital government and smart city programs
  • – insurance and prevention-focused organizations
  • – universities and research institutes
  • – sensor technology and digital health partners

Expected Societal and Economic Impact

  • – early detection of adverse health trends → fewer chronic conditions
  • – reduced long-term healthcare burden
  • – more efficient and targeted prevention strategies
  • – increased digital health awareness
  • – sustained healthcare cost savings

Alignment with the AVA Development Framework

Within this program, AVA operates as an analytical and coordinating intelligence layer, supporting:

  • – structuring and interpretation of biosensor-derived data,
  • – identification of trends and anomalies,
  • – guidance for prevention strategies and long-term planning.

The National Biosensor and Digital Health Monitoring Program thus completes and stabilizes the national Bio–Nano and health-technology program portfolio, providing a solid foundation for future large-scale health ecosystem initiatives.